Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
140,800
Employees140,800
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
140,800
Employees140,800

JNJ Key Statistics

Market cap
620.63B
Market cap620.63B
Price-Earnings ratio
29.71
Price-Earnings ratio29.71
Dividend yield
2.04%
Dividend yield2.04%
Average volume
7.25M
Average volume7.25M
High today
$259.51
High today$259.51
Low today
$256.15
Low today$256.15
Open price
$257.99
Open price$257.99
Volume
5.10M
Volume5.10M
52 Week high
$269.43
52 Week high$269.43
52 Week low
$154.80
52 Week low$154.80

Stock Snapshot

With a market cap of 620.63B, Johnson & Johnson(JNJ) trades at $257.60. The stock has a price-to-earnings ratio of 29.71 and currently yields dividends of 2.04%.

As of 2026-07-14, Johnson & Johnson(JNJ) stock has fluctuated between $256.15 and $259.51. The current price stands at $257.60, placing the stock +0.6% above today's low and -0.7% off the high.

The Johnson & Johnson(JNJ)'s current trading volume is 5.1M, compared to an average daily volume of 7.25M.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $269.43 and a 52-week low of $154.80.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $269.43 and a 52-week low of $154.80.

JNJ News

Nasdaq 3h
This Dividend King Has Raised Its Payout for More Than 60 Straight Years. But Is the Stock Still a Buy?

Key Points Johnson & Johnson raised its dividend for the 64th year in a row in April 2026. Growing drugs like Darzalex and Tremfya are offsetting the steep dr...

This Dividend King Has Raised Its Payout for More Than 60 Straight Years. But Is the Stock Still a Buy?
Simply Wall St 11h
Can Johnson & Johnson Trade At A Discount Despite Talc Risk?

Johnson & Johnson stock has delivered a strong 77.8% total return over the past five years, yet the latest valuation checks send a mixed message, with an intrin...

Can Johnson & Johnson Trade At A Discount Despite Talc Risk?
24/7 Wall St. 16h
How Much of Your Social Security Will You Actually Keep After Taxes?

How Much of Your Social Security Will You Actually Keep After Taxes? By Drew Wood Published Jul 13, 2:28PM EDT Quick Read Social Security tax thresholds froze...

How Much of Your Social Security Will You Actually Keep After Taxes?

Analyst ratings

69%

of 26 ratings
Buy
69.2%
Hold
26.9%
Sell
3.8%

More JNJ News

24/7 Wall St. 18h
JNJ Vs. KO: Which Dividend Stock Is The Better Buy?

This lithium producer surpassed a $1B private valuation, joining some of America's most powerful startups. Now you can invest in EnergyX alongside global giants...

JNJ Vs. KO: Which Dividend Stock Is The Better Buy?
TipRanks 21h
Johnson & Johnson price target raised to $287 from $265 at RBC Capital

RBC Capital raised the firm’s price target on Johnson & Johnson to $287 from $265 and keeps an Outperform rating on the shares as part of a broader research not...

24/7 Wall St. 22h
The Real Case for Buying Johnson & Johnson Before July 15

This lithium producer surpassed a $1B private valuation, joining some of America's most powerful startups. Now you can invest in EnergyX alongside global giants...

The Real Case for Buying Johnson & Johnson Before July 15
TipRanks 23h
Is Dividend King Johnson & Johnson a Buy Ahead of Earnings?

Johnson & Johnson (JNJ) is scheduled to report its fiscal second-quarter results before the market opens on July 15. JNJ stock is a “Dividend King” because it h...

NPR 1d
He was having a mental health crisis. Memphis task force agents came and shot him - NPR

...

He was having a mental health crisis. Memphis task force agents came and shot him - NPR
Nasdaq 2d
Billionaire Ken Griffin Boosted His Stake in This Dividend King by 146%. Here's Why It's a Dream Stock for Risk-Averse Investors.

Key Points Ken Griffin has a long track record of stock market gains, and he extended this into the first quarter of 2026. This Griffin stock makes a great ad...

Billionaire Ken Griffin Boosted His Stake in This Dividend King by 146%. Here's Why It's a Dream Stock for Risk-Averse Investors.
Barron's 2d
Inflation, Bank of America, Wells Fargo, Goldman, ASML, J&J, and More to Watch This Week

Markets Inflation, Bank of America, Wells Fargo, Goldman, ASML, J&J, and More to Watch This Week In this article SPX BAC GS WFC 2330 Equities rose last week, sh...

Inflation, Bank of America, Wells Fargo, Goldman, ASML, J&J, and More to Watch This Week

People also own

Based on the portfolios of people who own JNJ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.